Search Result "INNO-406"


New Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia

Journal: Current Pharmaceutical Biotechnology
Volume: 7 Issue: 5 Year: 2006 Page: 371-379
Author(s): Shinya Kimura, Eishi Ashihara, Taira Maekawa

Second Generation Abl Kinase Inhibitors and Novel Compounds to Eliminate the Bcr-Abl/T315I Clone

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 1 Issue: 3 Year: 2006 Page: 347-355
Author(s): Shinya Kimura

Targeted Drugs in Chronic Myeloid Leukemia

Journal: Current Medicinal Chemistry
Volume: 15 Issue: 2 Year: 2008 Page: 3036-3051
Author(s): Joanna Gora-Tybor, Tadeusz Robak

Tyrosine Kinase Blockers: New Hope for Successful Cancer Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9 Issue: 1 Year: 2009 Page: 66-76
Author(s): Dariusz Pytel, Tomasz Sliwinski, Tomasz Poplawski, Deborah Ferriola, Ireneusz Majsterek

Journal: Current Pharmaceutical Design
Volume: 15 Issue: 2 Year: 2009 Page: 120-133
Author(s): Bernhard A. Muller

Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9 Issue: 8 Year: 2009 Page: 853-863
Author(s): Manlio Tolomeo, Francesco Dieli, Nicola Gebbia, Daniele Simoni

Targeting BCR-ABL Oncoprotein for Leukemia Therapy: Current Biotechnology and Future Perspectives

Journal: Current Biotechnology
Volume: 1 Issue: 2 Year: 2012 Page: 175-183
Author(s): Min Shen,Q. Ping Dou

The Novel Role for Lyn in Integrin Signaling in Human Disease

Journal: Current Signal Transduction Therapy
Volume: 4 Issue: 1 Year: 2009 Page: 59-65
Author(s): Brian Tomkowicz, Andrzej Ptasznik

Life and Death of Leukemic Cells Under Bcr-Abl Signaling Control

Journal: Current Cancer Therapy Reviews
Volume: 5 Issue: 4 Year: 2009 Page: 303-309
Author(s): Junya Kuroda, Masafumi Taniwaki

Previous   Next

Go To   Results 1 - 1 of 59

Apply Filters

Volume Years
Article Type
    Publication Title
    Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy